ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients Receiving Stable Opioid Substitution Treatment: Pooled Analysis of Efficacy and Safety in Phase 2 and Phase 3 Trials
Authors
Puoti, M; Cooper, C; Sulkowski, MS; Foster, GR; Berg, T; Villa, E; Rodriguez-Perez, F; Rustgi, V; Wyles, DL; King, MCollections
- Centre for Immunobiology [1029]